Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D. Stereotactic radiosurgery (SRS) - Treatment option for recurrent glioblastoma multiforme (GBM) Cancer. 2005; 8 (10):2168–2173. doi: 10.1002/cncr.21429. [ Cross Ref ]...
Choose Specialty Biosimilars Brain Cancer Breast CancerBreast Cancer CAR T-cell Therapy COVID-19 Disparities in Cancer Care Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer Genitourinary CancersGenitourinary CancersGenitourinary Cancers Global Oncology Gynecol...
Stupp remarked in his presentation. When temozolomide was added to radiation, 5-year survival improved to 9.8%. Now, however, “EF-14 establishes a new landmark 5-year survival rate of 13%, and long-term remission in GBM is now possible.” ...
In addition to its synergy with radiation, TTFields therapy has been shown to enhance the effects of chemotherapy by increasing drug delivery to cancer cells, disrupting cell division, and sensitizing glioblastoma cells to temozolomide [9]. These results provided a strong rationale for the application...
The rise in prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes is expected to drive the glioblastoma multiforme (GBM) treatment market. However, it has been found that survival rate of patients suffering from GBM is relatively poor. ...
Glioblastoma multiforme (GBM), an extremely invasive and high-grade (grade IV) glioma, is the most common and aggressive form of brain cancer. It has a poor prognosis, with a median overall survival of only 11 months in the general GBM population and 14.6 to 21 months in clinical trial pa...
Vigeo Therapeutics, a clinical-stage immuno-oncology company pioneering novel cancer therapies, is pleased to announce that a complete response patient (CR) in Glioblastoma (GBM) cohort from first in human study VT1021-01 (NCT03364400) has now completed 3 full years ...
18where they were able to correctly identify disease presence. qMT was also used in characterizing the changes in brain tissue in HIV patient where it showed a significant reduction in MT parameter compared to healthy controls19. In cancer, and in particular in GBM, there have been very few ...
Despite advances in neurosurgical technology and techniques, the survival rate of GBM patients has remained relatively unchanged. The main treatments for GBM are associated with difficulties resulting from incomplete tumor resection and recurrence. In such situations, Photodynamic Therapy (PDT) is increasing...
BMC Cancer (2024) 24:89 Page 6 of 14 Fig. 3 EMP3 is a biomarker of gliomas with prognostic significance (A) and (B). Kaplan–Meier curves show that different expression levels of EMP3 in the CGGA and TCGA databases correlate with survival in glioma ...